Tags » Gleevec

Do Market Forces Really Work on Specialty Pricing?

I was rereading a post I produced for another site just one year ago on March 28th. The intent was to show how the branded drug market is distorted by pricing that has little to do with competition and inflation. 260 more words

Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade

http://www.nbcnews.com/health/cancer/cancer-pill-gleevec-keeps-patients-alive-well-decade-n730951

Everyone hopes and wishes for that last-minute cancer breakthrough that will save doomed patients. It almost never actually happens. With Gleevec, it did.

The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. 1,202 more words

Daily News

Gleevec 400mg | Glivec 400mg Novartis | Buy Imatinib Online


Imatinib Mesylate is a type of biological therapy called a tyrosine kinase inhibitor (TKI) which is used to treat certain types of leukemia, certain bone marrow diseases, a certain type of skin cancer, and certain intestinal tumors (eg, gastrointestinal stromal tumors ). 63 more words

#Gleevec 400 mg Online Price | Buy Gleevec Online | Novartis #Imatinib Gleevec


Matching up with the ever increasing requirements of the customers, our mail order pharmacy is involved in offering #Glivec/Gleevec Imatinib tablets by Novartis. By the crossing of time, Drugssquare, online medicine store have been able to recognize & acknowledge the various products requirements of our clients. 73 more words

Top News: #Leukemia

Here are the top read news for #Leukemia:

Side effects of leukaemia drug can be safely reduced by halving dose:

Under current guidelines, patients who achieve remission with TKI therapy are advised to continue taking the drugs indefinitely, yet it is unclear whether continued therapy is necessary for all patients. 402 more words

Infusion Nursing

Novartis's Q3 2016 net income $10,9B shorter than last year

Novartis has reported net income of $5.8 billion compared to $16.7 billion in the prior-year period.

Basic earnings per share decreased to $2.42 from $6.94. 113 more words

News

24th Month into Glivec

2 years into Glivec. We are optimistic and thank God for the blessings we received to see Dad doing well. On the last CT Scan we did not see any change to the size of the tumour. 431 more words

Dad's Health Journal